Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Digital PCR-based T Cell Quantification Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma.

de Lange M, Nell RJ, Lalai RN, Versluis M, Jordanova ES, Luyten GP, Jager MJ, van der Burg SH, Zoutman WH, van Hall T, van der Velden PA.

Mol Cancer Res. 2018 Aug 9. pii: molcanres.0114.2018. doi: 10.1158/1541-7786.MCR-18-0114. [Epub ahead of print]

PMID:
30093564
2.

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy.

Mohabati D, van Rijssen TJ, van Dijk EH, Luyten GP, Missotten TO, Hoyng CB, Yzer S, Boon CJ.

Clin Ophthalmol. 2018 Jun 7;12:1061-1070. doi: 10.2147/OPTH.S160956. eCollection 2018.

3.

Lack of tumour pigmentation in conjunctival melanoma is associated with light iris colour and worse prognosis.

Brouwer NJ, Marinkovic M, Luyten GPM, Shields CL, Jager MJ.

Br J Ophthalmol. 2018 May 18. pii: bjophthalmol-2018-312018. doi: 10.1136/bjophthalmol-2018-312018. [Epub ahead of print]

PMID:
29777046
4.

Pimasertib-associated ophthalmological adverse events.

van Dijk EHC, Kruit WHJ, Jager MJ, Luyten GPM, Vingerling JR, Boon CJF.

Acta Ophthalmol. 2018 Jan 16. doi: 10.1111/aos.13677. [Epub ahead of print]

PMID:
29338133
5.

Ruthenium-106 brachytherapy for iris and iridociliary melanomas.

Marinkovic M, Horeweg N, Laman MS, Bleeker JC, Ketelaars M, Peters FP, Luyten GPM, Creutzberg CL.

Br J Ophthalmol. 2018 Aug;102(8):1154-1159. doi: 10.1136/bjophthalmol-2017-310688. Epub 2017 Nov 9.

PMID:
29122824
6.

Treatment of conjunctival melanoma in a Dutch referral centre.

Brouwer NJ, Marinkovic M, van Duinen SG, Bleeker JC, Jager MJ, Luyten GPM.

Br J Ophthalmol. 2017 Nov 9. pii: bjophthalmol-2017-311082. doi: 10.1136/bjophthalmol-2017-311082. [Epub ahead of print]

PMID:
29122819
7.

Multiple Pigmented Conjunctival Lesions following Intravitreal Injections in a Patient with Uveal Melanoma.

Brouwer NJ, Luyten GPM, van Duinen SG, Jager MJ, Marinkovic M.

Ocul Oncol Pathol. 2017 Jul;3(2):113-116. doi: 10.1159/000452447. Epub 2016 Nov 9.

8.

PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.

Gezgin G, Luk SJ, Cao J, Dogrusöz M, van der Steen DM, Hagedoorn RS, Krijgsman D, van der Velden PA, Field MG, Luyten GPM, Szuhai K, Harbour JW, Jordanova ES, Heemskerk MHM, Jager MJ.

JAMA Ophthalmol. 2017 Jun 1;135(6):541-549. doi: 10.1001/jamaophthalmol.2017.0729.

9.

Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment.

Gezgin G, Dogrusöz M, van Essen TH, Kroes WGM, Luyten GPM, van der Velden PA, Walter V, Verdijk RM, van Hall T, van der Burg SH, Jager MJ.

Cancer Immunol Immunother. 2017 Jul;66(7):903-912. doi: 10.1007/s00262-017-1991-1. Epub 2017 Apr 8.

10.

A translucent vascularised iris granuloma in a patient with secondary syphilis.

de Jong Y, Haverkort ME, van Sorge AJ, Jansen C, Luyten GP, Joosse M.

Lancet Infect Dis. 2017 Mar;17(3):255-256. doi: 10.1016/S1473-3099(17)30071-3. Epub 2017 Feb 23. No abstract available.

PMID:
28244379
11.

The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status.

Dogrusöz M, Bagger M, van Duinen SG, Kroes WG, Ruivenkamp CA, Böhringer S, Andersen KK, Luyten GP, Kiilgaard JF, Jager MJ.

Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):833-842. doi: 10.1167/iovs.16-20212.

PMID:
28159971
12.

Isolated (hypoxic) hepatic perfusion with high-dose chemotherapy in patients with unresectable liver metastases of uveal melanoma: results from two experienced centres.

de Leede EM, Burgmans MC, Kapiteijn E, Luyten GP, Jager MJ, Tijl FG, Hartgrink HH, Grünhagen DJ, Rothbarth J, van de Velde CJ, Verhoef C, Vahrmeijer AL.

Melanoma Res. 2016 Dec;26(6):588-594.

PMID:
27513071
13.

Association of Axial Length With Risk of Uncorrectable Visual Impairment for Europeans With Myopia.

Tideman JW, Snabel MC, Tedja MS, van Rijn GA, Wong KT, Kuijpers RW, Vingerling JR, Hofman A, Buitendijk GH, Keunen JE, Boon CJ, Geerards AJ, Luyten GP, Verhoeven VJ, Klaver CC.

JAMA Ophthalmol. 2016 Dec 1;134(12):1355-1363. doi: 10.1001/jamaophthalmol.2016.4009.

PMID:
27768171
14.

Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes.

van Essen TH, van Pelt SI, Bronkhorst IH, Versluis M, Némati F, Laurent C, Luyten GP, van Hall T, van den Elsen PJ, van der Velden PA, Decaudin D, Jager MJ.

PLoS One. 2016 Oct 20;11(10):e0164292. doi: 10.1371/journal.pone.0164292. eCollection 2016.

15.

Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome.

Marinkovic M, Horeweg N, Fiocco M, Peters FP, Sommers LW, Laman MS, Bleeker JC, Ketelaars M, Luyten GP, Creutzberg CL.

Eur J Cancer. 2016 Nov;68:106-113. doi: 10.1016/j.ejca.2016.09.009. Epub 2016 Oct 12.

PMID:
27741435
16.

[A woman with iris heterochromia].

Birker IL, Boons LS, Luyten GP.

Ned Tijdschr Geneeskd. 2016;160:D197. Dutch.

PMID:
27334084
17.

Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer Patients.

van Dijk EH, Duits DE, Versluis M, Luyten GP, Bergen AA, Kapiteijn EW, de Lange MJ, Boon CJ, van der Velden PA.

Medicine (Baltimore). 2016 May;95(18):e3457. doi: 10.1097/MD.0000000000003457.

18.

Clinical evaluation of ultra-high-field MRI for three-dimensional visualisation of tumour size in uveal melanoma patients, with direct relevance to treatment planning.

Beenakker JW, Ferreira TA, Soemarwoto KP, Genders SW, Teeuwisse WM, Webb AG, Luyten GP.

MAGMA. 2016 Jun;29(3):571-7. doi: 10.1007/s10334-016-0529-4. Epub 2016 Feb 25.

19.

Donor sclera-wrapped acrylic orbital implants following enucleation: experience in 179 patients in the Netherlands.

Jongman HP, Marinkovic M, Notting I, Koetsier L, Swart W, Schalij-Delfos NE, Bleeker J, Jager MJ, Luyten GP.

Acta Ophthalmol. 2016 May;94(3):253-6. doi: 10.1111/aos.12960. Epub 2016 Feb 23.

20.

Biocompatibility of a fish scale-derived artificial cornea: Cytotoxicity, cellular adhesion and phenotype, and in vivo immunogenicity.

van Essen TH, van Zijl L, Possemiers T, Mulder AA, Zwart SJ, Chou CH, Lin CC, Lai HJ, Luyten GPM, Tassignon MJ, Zakaria N, El Ghalbzouri A, Jager MJ.

Biomaterials. 2016 Mar;81:36-45. doi: 10.1016/j.biomaterials.2015.11.015. Epub 2015 Dec 1.

PMID:
26717247
21.

Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.

de Lange MJ, van Pelt SI, Versluis M, Jordanova ES, Kroes WG, Ruivenkamp C, van der Burg SH, Luyten GP, van Hall T, Jager MJ, van der Velden PA.

Oncotarget. 2015 Nov 10;6(35):37824-35. doi: 10.18632/oncotarget.5637.

22.

Radiation Treatment Affects Chromosome Testing in Uveal Melanoma.

Dogrusöz M, Kroes WG, van Duinen SG, Creutzberg CL, Versluis M, Bleeker JC, Marinkovic M, Luyten GP, Jager MJ.

Invest Ophthalmol Vis Sci. 2015 Sep;56(10):5956-64. doi: 10.1167/iovs.15-17092.

PMID:
26393462
23.

Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism.

de Lange MJ, Razzaq L, Versluis M, Verlinde S, Dogrusöz M, Böhringer S, Marinkovic M, Luyten GP, de Keizer RJ, de Gruijl FR, Jager MJ, van der Velden PA.

PLoS One. 2015 Sep 14;10(9):e0138002. doi: 10.1371/journal.pone.0138002. eCollection 2015.

24.

Dutch Translation and Psychometric Testing of the 9-Item Shared Decision Making Questionnaire (SDM-Q-9) and Shared Decision Making Questionnaire-Physician Version (SDM-Q-Doc) in Primary and Secondary Care.

Rodenburg-Vandenbussche S, Pieterse AH, Kroonenberg PM, Scholl I, van der Weijden T, Luyten GP, Kruitwagen RF, den Ouden H, Carlier IV, van Vliet IM, Zitman FG, Stiggelbout AM.

PLoS One. 2015 Jul 7;10(7):e0132158. doi: 10.1371/journal.pone.0132158. eCollection 2015.

25.

Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma.

van Dijk EH, van Herpen CM, Marinkovic M, Haanen JB, Amundson D, Luyten GP, Jager MJ, Kapiteijn EH, Keunen JE, Adamus G, Boon CJ.

Ophthalmology. 2015 Sep;122(9):1907-16. doi: 10.1016/j.ophtha.2015.05.027. Epub 2015 Jun 26.

PMID:
26123090
26.

The genetic basis of uveal melanoma.

Nielsen M, Dogrusöz M, Bleeker JC, Kroes WG, van Asperen CA, Marinkovic M, Luyten GP, Jager MJ.

J Fr Ophtalmol. 2015 Jun;38(6):516-21. doi: 10.1016/j.jfo.2015.04.003. Epub 2015 May 11.

27.

Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.

Versluis M, de Lange MJ, van Pelt SI, Ruivenkamp CA, Kroes WG, Cao J, Jager MJ, Luyten GP, van der Velden PA.

PLoS One. 2015 Mar 12;10(3):e0116371. doi: 10.1371/journal.pone.0116371. eCollection 2015.

28.

Automated retinal topographic maps measured with magnetic resonance imaging.

Beenakker JW, Shamonin DP, Webb AG, Luyten GP, Stoel BC.

Invest Ophthalmol Vis Sci. 2015 Jan 15;56(2):1033-9. doi: 10.1167/iovs.14-15161.

PMID:
25593030
29.

Prognostic parameters in uveal melanoma and their association with BAP1 expression.

van Essen TH, van Pelt SI, Versluis M, Bronkhorst IH, van Duinen SG, Marinkovic M, Kroes WG, Ruivenkamp CA, Shukla S, de Klein A, Kiliç E, Harbour JW, Luyten GP, van der Velden PA, Verdijk RM, Jager MJ.

Br J Ophthalmol. 2014 Dec;98(12):1738-43. doi: 10.1136/bjophthalmol-2014-305047. Epub 2014 Aug 21.

30.

Effect of hypoxic stress on migration and characteristics of monocytes in uveal melanoma.

Bronkhorst IH, Jehs TM, Dijkgraaf EM, Luyten GP, van der Velden PA, van der Burg SH, Jager MJ.

JAMA Ophthalmol. 2014 May;132(5):614-21.

PMID:
24626595
31.

High-resolution MRI of uveal melanoma using a microcoil phased array at 7 T.

Beenakker JW, van Rijn GA, Luyten GP, Webb AG.

NMR Biomed. 2013 Dec;26(12):1864-9. doi: 10.1002/nbm.3041. Epub 2013 Oct 7.

PMID:
24123279
32.

Implantation of phakic intraocular lens in 3 patients with oculocutaneous albinism.

van Rijn GA, Snoek C, Joosse M, Saxena R, Luyten GP.

J Cataract Refract Surg. 2013 Oct;39(10):1604-8. doi: 10.1016/j.jcrs.2013.08.008.

PMID:
24075162
33.

A fish scale-derived collagen matrix as artificial cornea in rats: properties and potential.

van Essen TH, Lin CC, Hussain AK, Maas S, Lai HJ, Linnartz H, van den Berg TJ, Salvatori DC, Luyten GP, Jager MJ.

Invest Ophthalmol Vis Sci. 2013 May 7;54(5):3224-33. doi: 10.1167/iovs.13-11799.

PMID:
23580482
34.

Shifting exudative age-related macular degeneration patients to ranibizumab after insufficient response to bevacizumab.

de Geus SJ, Jager MJ, Luyten GP, Dijkman G.

Acta Ophthalmol. 2013 Aug;91(5):e411-3. doi: 10.1111/aos.12090. Epub 2013 Apr 1. No abstract available.

35.

Analysis of inflammatory cells in uveal melanoma after prior irradiation.

Vu TH, Bronkhorst IH, Versluis M, Marinkovic M, van Duinen SG, Vrolijk J, Luyten GP, Jager MJ.

Invest Ophthalmol Vis Sci. 2013 Jan 14;54(1):360-9. doi: 10.1167/iovs.12-9424.

PMID:
23211827
36.

Corneal endothelial cell density after ruthenium plaque radiation therapy for iris melanoma patients.

Razzaq L, Marinkovic M, Jager MJ, Bleeker J, Luyten GP, de Keizer RJ.

Acta Ophthalmol. 2012 Nov;90(7):e577-9. doi: 10.1111/j.1755-3768.2012.02389.x. No abstract available.

37.

Bevacizumab and intraocular tumors: an intriguing paradox.

el Filali M, Ly LV, Luyten GP, Versluis M, Grossniklaus HE, van der Velden PA, Jager MJ.

Mol Vis. 2012;18:2454-67. Epub 2012 Oct 5.

38.

High levels of Hdmx promote cell growth in a subset of uveal melanomas.

de Lange J, Teunisse AF, Vries MV, Lodder K, Lam S, Luyten GP, Bernal F, Jager MJ, Jochemsen AG.

Am J Cancer Res. 2012;2(5):492-507. Epub 2012 Aug 20.

39.

Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma.

Nagarkatti-Gude N, Bronkhorst IH, van Duinen SG, Luyten GP, Jager MJ.

Invest Ophthalmol Vis Sci. 2012 Oct 1;53(11):6748-55. doi: 10.1167/iovs.12-10123.

PMID:
22930720
40.

Concomitant choroidal melanoma and non-hodgkin lymphoma in two adult patients: case report.

Vlaskamp M, de Wolff-Rouendaal D, Jansen PM, Luyten GP.

Case Rep Ophthalmol. 2012 May;3(2):209-13. doi: 10.1159/000339654. Epub 2012 Jun 19.

41.

Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma.

Bronkhorst IH, Vu TH, Jordanova ES, Luyten GP, Burg SH, Jager MJ.

Invest Ophthalmol Vis Sci. 2012 Aug 9;53(9):5370-8. doi: 10.1167/iovs.11-9280.

PMID:
22743317
42.

Magnetic resonance compatibility of intraocular lenses measured at 7 Tesla.

van Rijn GA, Mourik JE, Teeuwisse WM, Luyten GP, Webb AG.

Invest Ophthalmol Vis Sci. 2012 Jun 8;53(7):3449-53. doi: 10.1167/iovs.12-9610.

PMID:
22538424
43.

Fuchs' adenoma of the choroid simulating a choroidal hemangioma.

Razzaq L, Marinkovic M, Swart W, van Duinen SG, Keunen JE, Luyten GP.

Case Rep Ophthalmol. 2012 Jan;3(1):83-6. doi: 10.1159/000336989. Epub 2012 Mar 7.

44.

A comparison of HLA genotype with inflammation in uveal melanoma.

van Essen TH, Bronkhorst IH, Maat W, Verduyn W, Roelen DL, Luyten GP, Jager MJ.

Invest Ophthalmol Vis Sci. 2012 May 4;53(6):2640-6. doi: 10.1167/iovs.11-8901.

PMID:
22447860
45.

Mesectodermal suprauveal iridociliary leiomyoma: transscleral excision without postoperative iris defect.

Razzaq L, Semenova EA, Marinkovic M, de Keizer RJ, Van Duinen SG, Luyten GP.

Arch Ophthalmol. 2011 Dec;129(12):1635-7. doi: 10.1001/archophthalmol.2011.342. No abstract available.

PMID:
22159691
46.

Complications due to bovine pericardium used to cover acrylic implants after enucleation and tubes of aqueous devices.

De Vries FR, Notting IC, Marinkovic M, Schalij-Delfos NE, Luyten GP.

Eye (Lond). 2012 Feb;26(2):336. doi: 10.1038/eye.2011.294. Epub 2011 Nov 11. No abstract available.

47.

Anti-angiogenic therapy in uveal melanoma.

el Filali M, van der Velden PA, Luyten GP, Jager MJ.

Dev Ophthalmol. 2012;49:117-36. doi: 10.1159/000329591. Epub 2011 Oct 21. Review.

PMID:
22042017
48.

Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results.

Muller K, Naus N, Nowak PJ, Schmitz PI, de Pan C, van Santen CA, Marijnissen JP, Paridaens DA, Levendag PC, Luyten GP.

Radiother Oncol. 2012 Feb;102(2):219-24. doi: 10.1016/j.radonc.2011.06.038. Epub 2011 Aug 22.

PMID:
21864922
49.

Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.

Bronkhorst IH, Maat W, Jordanova ES, Kroes WG, Schalij-Delfos NE, Luyten GP, Jager MJ.

Arch Pathol Lab Med. 2011 Aug;135(8):1042-7. doi: 10.5858/2010-0477-OAR1.

PMID:
21809997
50.

Pancorneal contact lens with a toric edge: a new concept in keratoconus.

Kamar S, Vervaet C, Luyten GP, Jager MJ.

Eur J Ophthalmol. 2011 Nov-Dec;21(6):685-90. doi: 10.5301/EJO.2011.6505.

PMID:
21462156

Supplemental Content

Loading ...
Support Center